Humacyte manufactures lab-grown human blood vessels designed for implantation into patients without the risk of immune system rejection. These bioengineered tissues are used to treat physical trauma, provide access for dialysis, and repair damaged cardiovascular systems. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?